SCHEMBL8555873

SCHEMBL8555873

O=C([CH]c1ccccc1)Nc1nccs1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.74
SMN1; SMN2 Q16637 8/20 0.74
NPC1 O15118 8/20 0.74
KDM4E B2RXH2 5/20 0.74
KMT2A Q03164 4/20 0.74
TP53 P04637 3/20 0.74
NFKB1 P19838 2/20 0.74
NFKB2 Q00653 2/20 0.74
RELA Q04206 2/20 0.74
STAT1 P42224 1/20 0.63
MEN1 O00255 3/20 0.62
LMNA P02545 3/20 0.62
HPGD P15428 3/20 0.62
PTGS2 P35354 1/20 0.60
AURKA O14965 1/20 0.59
PIM1 P11309 1/20 0.59
CDK2 P24941 1/20 0.59
GSK3B P49841 1/20 0.59
ALDH1A1 P00352 3/20 0.57
CYP1A2 P05177 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22187038 0.79 SMN1; SMN2 (0.75) RAB9ASMN1; SMN2NPC1KDM4EKMT2A
SCHEMBL4565333 0.78 RAB9A (0.59) RAB9ASMN1; SMN2NPC1KDM4EKMT2A
SCHEMBL32690316 0.76 RAB9A (0.66) RAB9ASMN1; SMN2NPC1KDM4EKMT2A
SCHEMBL19974151 0.76 RAB9A (0.66) RAB9ASMN1; SMN2NPC1KDM4EKMT2A
SCHEMBL995829 0.76 NPC1 (1.00) RAB9ASMN1; SMN2NPC1KDM4EKMT2A
SCHEMBL19974134 0.76 RAB9A (0.66) RAB9ASMN1; SMN2NPC1KDM4EKMT2A
SCHEMBL28398606 0.76 RAB9A (0.76) RAB9ASMN1; SMN2NPC1KDM4EKMT2A
SCHEMBL4600722 0.74 AURKA (1.00) RAB9ASMN1; SMN2NPC1KDM4EKMT2A
Hydrochloric Acid SCHEMBL27594584 0.74 NPC1 (0.97) RAB9ASMN1; SMN2NPC1KDM4EKMT2A
SCHEMBL7375 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815108-A1 CYCLIC UREA HIV PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-01-07 EP claimed
US-5683999-A Cyclic urea HIV protease inhibitors THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-11-04 US claimed
EP-0815108-A1 CYCLIC UREA HIV PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-01-07 EP disclosed
US-5683999-A Cyclic urea HIV protease inhibitors THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-11-04 US disclosed